Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | ENO2 |
| Upstream (Parents) |
|---|
| (<<) ANTXR1 → ENO2 |
| (<<) CAPRIN2 → ENO2 |
| (<<) DUSP5 → ENO2 |
| (<<) GAPDH → ENO2 |
| (<<) KLHDC5 → ENO2 |
| (<<) NCOR2 → ENO2 |
| (<<) NDRG1 → ENO2 |
| (<<) NOS3 → ENO2 |
| (<<) PKM2 → ENO2 |
| (<<) RNF138 → ENO2 |
| (<<) S100A2 → ENO2 |
| (<<) SERPINB1 → ENO2 |
| (<<) SERPINB5 → ENO2 |
| (<<) SMAD2 → ENO2 |
| (<<) SMOX → ENO2 |
| (<<) SPINK1 → ENO2 |
| (<<) STAT4 → ENO2 |
| (<<) STAT5A → ENO2 |
| (<<) TMEM158 → ENO2 |
| (<<) TMEM88 → ENO2 |
| (<<) UBE2D1 → ENO2 |
| (<<) VEGFA → ENO2 |
| Downstream (Children) |
|---|
| ENO2 → BMP8B (>>) |
| ENO2 → FNDC4 (>>) |
| ENO2 → GNAS (>>) |
| ENO2 → HYAL1 (>>) |
| ENO2 → IGFBP3 (>>) |
| ENO2 → KISS1R (>>) |
| ENO2 → KRT16 (>>) |
| ENO2 → NFIA (>>) |
| ENO2 → PPP1R3D (>>) |
| ENO2 → RAF1 (>>) |
| ENO2 → SOCS2 (>>) |
| ENO2 → SOX17 (>>) |
| ENO2 → STC2 (>>) |
| ENO2 → TMCC3 (>>) |
